After receiving aducanumab infusions, patients had MRI-guided focused ultrasound targeting specific brain regions to open the blood-brain barrier and optimize medication.
Two hours after receiving aducanumab infusion, patients had MRI-guided focused ultrasound targeted at specific brain regions to open up the blood-brain barrier